A Partner in Health
A new chapter, a new approach. Collaborating with physicians and other healthcare professionals, focusing on R&D and maintaining clinical leadership add up to innovative medical solutions that make a difference.
Work with Us
Join Covidien, where we appreciate your talent, your experience and your passion for your work. Our culture thrives because we invest in our colleagues' growth and reward their efforts.
Visit Us
Covidien will be at the Association for Professionals in Infection Control and Epidemiology in Ft. Lauderdale from June 7 – 11, 2009
Covidien Medical Supplies will be at the Medical Design and Manufacturing East in New York from June 9 – 11, 2009
Covidien Respiratory will be at the Associated Professional Sleep Societies in Seattle from June 6 - 11, 2009
COV (NYSE)
| Price: | $44.05 |
| Change: | (0.13) |
| Volume: | 1,471,815 |
Minimum 20 minute delay
-
11/6/2009 4:19:00 PM
Covidien Completes Acquisition of Aspect Medical Systems Inc.
DUBLIN--(BUSINESS WIRE)--Nov. 6, 2009-- Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of Aspect Medical Systems Inc. for an aggregate consideration of approximately $210 million… -
11/6/2009 7:02:00 AM
Covidien Successfully Completes Tender Offer for Shares of Aspect Medical Systems, Inc.
DUBLIN--(BUSINESS WIRE)--Nov. 6, 2009-- Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the successful completion of its tender offer through its subsidiary, Transformer Delaware Corp., to purchase all of the outstanding shares of common stock of … -
11/5/2009 7:04:00 AM
FDA Approves Pennsaid(R) Topical Solution
Covidien, Nuvo Research Inc. Collaboration Achieves Significant Milestone in Support of Covidien’s Expansion in Branded Pain Management Market ST. LOUIS & MISSISSAUGA, Ontario--(BUSINESS WIRE)--Nov. 5, 2009-- Covidien (NYSE:COV), a leading global provider of healthcare products, and … -
11/4/2009 7:01:00 AM
Covidien to Present at Credit Suisse Healthcare Conference
MANSFIELD, Mass.--(BUSINESS WIRE)--Nov. 4, 2009-- Covidien (NYSE: COV) will present at the Credit Suisse 18th Annual Healthcare Conference in Phoenix on Wednesday, November 11, 2009. Charles J. Dockendorff, Executive Vice President and Chief Financial Officer, will discuss the Company in a presentation scheduled to begin at …